| Mechanistic insights into a novel chromone-appended Cu (II) anticancer drug entity: in vitro binding profile with DNA/RNA substrates and cytotoxic activity against MCF-7 and … I Yousuf, F Arjmand, S Tabassum, L Toupet, RA Khan, MA Siddiqui Dalton Transactions 44 (22), 10330-10342, 2015 | 90 | 2015 |
| Synthesis and spectroscopic characterization of diorganotin (IV) complexes of N′-(4-hydroxypent-3-en-2-ylidene) isonicotinohydrazide: chemotherapeutic potential validation by … S Yadav, I Yousuf, M Usman, M Ahmad, F Arjmand, S Tabassum RSC Advances 5 (63), 50673-50690, 2015 | 73 | 2015 |
| Advancement of metal compounds as therapeutic and diagnostic metallodrugs: Current frontiers and future perspectives I Yousuf, M Bashir, F Arjmand, S Tabassum Coordination Chemistry Reviews 445, 214104, 2021 | 68 | 2021 |
| Synthesis, characterization and in vitro DNA binding of chromone Schiff base organotin (IV) complexes F Arjmand, I Yousuf Journal of Organometallic Chemistry 743, 55-62, 2013 | 58 | 2013 |
| Synthesis, crystal structure and antiproliferative activity of Cu (II) nalidixic acid–DACH conjugate: Comparative in vitro DNA/RNA binding profile, cleavage activity and … F Arjmand, I Yousuf, T ben Hadda, L Toupet European Journal of Medicinal Chemistry 81, 76-88, 2014 | 54 | 2014 |
| Multispectroscopic insight, morphological analysis and molecular docking studies of CuII-based chemotherapeutic drug entity with human serum albumin (HSA) and bovine serum … I Yousuf, M Bashir, F Arjmand, S Tabassum Journal of Biomolecular Structure and Dynamics, 2018 | 43 | 2018 |
| Enantiomeric fluoro-substituted benzothiazole Schiff base-valine Cu (II)/Zn (II) complexes as chemotherapeutic agents: DNA binding profile, cleavage activity, MTT assay and … R Alizadeh, I Yousuf, M Afzal, S Srivastav, S Srikrishna, F Arjmand Journal of Photochemistry and Photobiology B: Biology 143, 61-73, 2015 | 40 | 2015 |
| Design and synthesis of enantiomeric (R)-and (S)-copper (II) and diorganotin (IV)-based antitumor agents: Their in vitro DNA binding profile, cleavage efficiency and … F Arjmand, M Muddassir, I Yousuf Journal of Photochemistry and Photobiology B: Biology 136, 62-71, 2014 | 38 | 2014 |
| Metal complexes of NSAIDs as potent anti-tumor chemotherapeutics: Mechanistic insights into cytotoxic activity via multiple pathways primarily by inhibition of COX–1 and COX–2 … HY Khan, S Parveen, I Yousuf, S Tabassum, F Arjmand Coordination Chemistry Reviews 453, 214316, 2022 | 30 | 2022 |
| Recent advances in metallodrug-like molecules targeting non-coding RNAs in cancer chemotherapy F Arjmand, Z Afsan, S Sharma, S Parveen, I Yousuf, S Sartaj, ... Coordination Chemistry Reviews 387, 47-59, 2019 | 30 | 2019 |
| Design and synthesis of new Zn(II) nalidixic acid–DACH based Topo-II inhibiting molecular entity: Chemotherapeutic potential validated by its in vitro binding profile … F Arjmand, I Yousuf, M Afzal, L Toupet Inorganica Chimica Acta 421, 26-37, 2014 | 29 | 2014 |
| Design and synthesis of a DNA intercalative half-sandwich organoruthenium (ii)–chromone complex: cytotoxicity evaluation and topoisomerase Iα inhibition assay I Yousuf, F Arjmand, S Tabassum, M Ahmad New Journal of Chemistry 43 (14), 5475-5487, 2019 | 23 | 2019 |
| Crystal structure determination, spectroscopic characterization and biological profile of a tailored ionic molecular entity, Sn (iv) iminodiacetic acid–piperazinediium … F Arjmand, I Yousuf, Y Zaidi, L Toupet RSC advances 5 (21), 16250-16264, 2015 | 23 | 2015 |
| Single X-ray crystal structure, DFT studies and topoisomerase I inhibition activity of a tailored ionic Ag (I) nalidixic acid–piperazinium drug entity specific for pancreatic … I Yousuf, M Usman, M Ahmad, S Tabassum, F Arjmand New Journal of Chemistry 42 (1), 506-519, 2018 | 20 | 2018 |
| Exploring the intermolecular interactions and contrasting binding of flufenamic acid with hemoglobin and lysozyme: A biophysical and docking insight SS Ansari, I Yousuf, F Arjmand, MK Siddiqi, S Naqvi International journal of biological macromolecules 116, 1105-1118, 2018 | 19 | 2018 |
| In vitro DNA binding profile of enantiomeric dinuclear Cu (II)/Ni (II) complexes derived from l–/d–histidine–terepthaldehyde reduced Schiff base as potential chemotherapeutic … I Yousuf, F Arjmand Journal of Photochemistry and Photobiology B: Biology 164, 83-95, 2016 | 18 | 2016 |
| An overview of advancement of organoruthenium (II) complexes as prospective anticancer agents M Bashir, IA Mantoo, F Arjmand, S Tabassum, I Yousuf Coordination Chemistry Reviews 487, 215169, 2023 | 13 | 2023 |
| New ionic Cu (II) and Co (II) DACH–flufenamate conjugate complexes: spectroscopic characterization, single x–ray studies and cytotoxic activity on human cancer cell lines HY Khan, S Zehra, S Parveen, I Yousuf, S Tabassum, F Arjmand ChemistrySelect 3 (45), 12764-12772, 2018 | 13 | 2018 |
| Syntheses, structural characterization, and cytotoxicity assessment of novel Mn (II) and Zn (II) complexes of aroyl-hydrazone Schiff base Ligand M Bashir, AA Dar, I Yousuf ACS omega 8 (3), 3026-3042, 2023 | 11 | 2023 |
| Mixed Ni (II) and Co (II) complexes of nalidixic acid drug: Synthesis, characterization, DNA/BSA binding profile and in vitro cytotoxic evaluation against MDA-MB-231 and HepG2 … M Bashir, I Yousuf, CP Prasad Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 271, 120910, 2022 | 10 | 2022 |
Prof. Sartaj TabassumDepartment of Chemistry,Aligarh Muslim UniversityVerified email at amu.ac.in
